Published in FDA Law Weekly, September 22nd, 2005
The patent, titled "Treatment of Premature Ejaculation," relates to various methods of treatment delivery via nasal (mucosal) inhalation and topical application of certain formulations, which are used in treatment programs for premature ejaculation. These formulations have previously been used to treat PE and other medical conditions.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.